DIMETANE-DX Trademark

Trademark Overview

On Thursday, November 3, 2016, a trademark application was filed for DIMETANE-DX with the United States Patent and Trademark Office. The USPTO has given the DIMETANE-DX trademark a serial number of 87225103. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, June 8, 2020. This trademark is owned by Casper Pharma LLC. The DIMETANE-DX trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations for the treatment of bronchitis, rhinitis, sinusitis, respiratory congestion, and respiratory ailments, none of the foregoing consisting of products specifically marketed or specifically intended for pediatric use
dimetane-dx

General Information

Serial Number87225103
Word MarkDIMETANE-DX
Filing DateThursday, November 3, 2016
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, June 8, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 21, 2017

Trademark Statements

Goods and Servicespharmaceutical preparations for the treatment of bronchitis, rhinitis, sinusitis, respiratory congestion, and respiratory ailments, none of the foregoing consisting of products specifically marketed or specifically intended for pediatric use

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, November 7, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCasper Pharma LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressEast Brunswick, NJ 08816
Party NameCasper Pharma LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressEast Brunswick, NJ 08816

Trademark Events

Event DateEvent Description
Monday, June 8, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, June 8, 2020ABANDONMENT - NO USE STATEMENT FILED
Tuesday, September 24, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 20, 2019EXTENSION 3 GRANTED
Friday, September 20, 2019EXTENSION 3 FILED
Friday, September 20, 2019TEAS EXTENSION RECEIVED
Wednesday, February 6, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, February 4, 2019EXTENSION 2 GRANTED
Monday, February 4, 2019EXTENSION 2 FILED
Monday, February 4, 2019TEAS EXTENSION RECEIVED
Thursday, August 9, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 7, 2018EXTENSION 1 GRANTED
Tuesday, August 7, 2018EXTENSION 1 FILED
Tuesday, August 7, 2018TEAS EXTENSION RECEIVED
Tuesday, August 7, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, July 30, 2018ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, July 30, 2018TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, July 30, 2018ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, July 30, 2018TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, March 20, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, February 8, 2018TTAB RELEASE CASE TO TRADEMARKS
Thursday, February 8, 2018OPPOSITION TERMINATED NO. 999999
Thursday, February 8, 2018OPPOSITION DISMISSED NO. 999999
Friday, August 18, 2017OPPOSITION INSTITUTED NO. 999999
Tuesday, April 11, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, April 11, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, March 21, 2017EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, February 21, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 21, 2017PUBLISHED FOR OPPOSITION
Wednesday, February 1, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sunday, January 15, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, January 6, 2017ASSIGNED TO EXAMINER
Monday, November 7, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, November 7, 2016NEW APPLICATION ENTERED IN TRAM

Related Keywords

dimetane respiratory specifically consisting foregoing pediatric products marketed none intended ailments